Of clinical importance, in our comprehensive sample collection, ST6GAL1 expression loss correlated with clinico-pathological metastasis, i.e. regional lymph node invasion, implying a possible tumor suppressive role for ST6GAL1 in advanced bladder cancer stages. The gene discussed is ST6GAL1; the disease is urinary bladder carcinoma.